Autoimmune Disease Animal Model Innovation: Your Partner for Drug & Therapy Development
At Protheragen, we stand at the vanguard of autoimmune disease research, delivering state-of-the-art animal model development services meticulously designed to expedite the discovery and advancement of groundbreaking drugs and therapies. Our team of seasoned experts is unwavering in their commitment to offering holistic solutions that seamlessly connect scientific research with clinical application. By harnessing our vast experience and cutting-edge technology, we empower our clients to confidently and precisely navigate the intricate landscape of autoimmune disease therapeutic development.
Download
Optional Autoimmune Disease Animal Models
| Model Name | Construction Method | Application |
|---|---|---|
| TNFα-transgenic arthritis | Genetic modification to overexpress TNFα | Ideal for studying the role of TNFα in arthritis and testing TNF inhibitors as potential therapies. Also used to evaluate the efficacy of novel anti-inflammatory drugs. |
| Collagen-induced arthritis (CIA) | Immunization with type II collagen and adjuvant | Widely used to investigate the pathogenesis of rheumatoid arthritis (RA) and screen potential therapies, including biologics and small molecules. Also helps in understanding the immune response in RA. |
| MRL/lpr mouse lupus model | Spontaneous development due to genetic background | Provides insights into the mechanisms of systemic lupus erythematosus (SLE) and is used to evaluate the efficacy of immunosuppressive and anti-inflammatory therapies. Also valuable for studying renal involvement in SLE. |
| DSS-induced IBD model | Administration of dextran sulfate sodium (DSS) | Useful for exploring the pathogenesis of inflammatory bowel disease (IBD) and testing treatments for ulcerative colitis and Crohn's disease. Also helps in understanding the role of gut microbiota in IBD. |
| Non-obese diabetic (NOD) mouse | Spontaneous development due to genetic susceptibility | A key model for investigating the mechanisms of type 1 diabetes and developing therapies to prevent or treat autoimmune diabetes. Also used to study pancreatic islet inflammation and beta-cell destruction. |
| Experimental autoimmune encephalomyelitis (EAE) | Immunization with myelin antigens and adjuvant | A standard model for studying multiple sclerosis (MS) pathogenesis and testing neuroprotective and immunomodulatory therapies. Also used to investigate the role of T cells and cytokines in MS. |
| BB rat diabetes model | Spontaneous development due to genetic susceptibility | Provides a valuable platform for researching type 1 diabetes mechanisms and testing immunotherapies and interventions to prevent or delay disease onset. |
| MOG-induced EAE model | Immunization with myelin oligodendrocyte glycoprotein (MOG) | Investigates MS-like demyelination and is used to test remyelination therapies and neuroprotective agents. Also helps in understanding the role of myelin-specific T cells in disease progression. |
| ... | ... | ... |
cGVHD-SLE Mouse Model Development
Chronic Graft-versus-Host Disease (cGVHD) is an inflammatory condition that typically occurs months to years after hematopoietic stem cell transplantation. It is characterized by skin damage, liver disease, pulmonary involvement, and systemic illness. To better understand the mechanisms of cGVHD and explore potential treatments, a mouse model resembling Systemic Lupus Erythematosus (SLE) has been established.
Fig 1. Spleen and anti-dsDNA level.
Pristane-Induced SLE Mouse Model
Pristane-induced mouse models showed elevated serum IgG and anti-dsDNA levels at 3 and 6 months, closely mimicking human SLE with joint and renal lesions. This model provides a valuable platform for SLE research.
Fig 2. Pristane induces phenotypic changes in mouse models.
IgA Nephropathy (IgAN) Animal Model Development
IgA Nephropathy (IgAN) is a prevalent form of primary glomerular disease, distinguished by the deposition of IgA within the glomeruli. Characterized by recurrent gross or microscopic hematuria, potentially accompanied by proteinuria, IgAN shows an increasing incidence year by year with highly variable prognoses. The pathogenesis of IgAN remains not fully understood, underscoring the importance of developing animal models that mimic human clinical pathophysiology for studying the disease's mechanisms and exploring clinical treatments.
Fig 3. The ratio of urine albumin to creatinine in the two groups of mice.
Androgenetic Alopecia (AGA) Mouse Model Development
Androgenetic Alopecia (AGA), also known as androgenetic hair loss or male pattern baldness, is a hair loss condition influenced by genetic factors and androgens, affecting both men and women, though it is more common and pronounced in men. AGA can be influenced by various genetic factors, including gene variations related to androgen metabolism and hair follicle growth cycle regulation. Androgens bind to androgen receptors in hair follicles in specific areas of the scalp, such as the frontal and vertex regions, leading to gradual miniaturization and degeneration of the follicles.
Fig 4. Changes in the body weight and arthritis score of mice.
Our Advantages
- Expertise in Autoimmune Disease Modeling: With a dedicated team of scientists, we specialize in developing models that closely mimic human autoimmune conditions.
- Comprehensive Preclinical Services: We offer a full spectrum of services, from model development to efficacy testing, ensuring a seamless research process.
- Customizable Solutions: We work closely with our partners to tailor our services to meet the specific needs of each project.
If you are interested in our services, please feel free to contact us.